Rein Therapeutics to Present at Upcoming September Investor Conferences
Rein Therapeutics announced that its CEO, Brian Windsor, will present at two key investor conferences in September 2026: the Cantor Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference. The company focuses on developing first-in-class therapies for orphan pulmonary and fibrosis diseases, with its lead produc…